s6y

Cannapharmarx, Inc.

OTC
CPMD
CIK
1081938
Industry
Pharmaceutical Preparations
Incorporated in
Delaware
Fiscal year ends
December 31
SEC filer category
Non-accelerated filer, Smaller reporting company
Employer ID (EIN)
27-4635140
Formerly
Golden Dragon Holding Co., CCVG, Inc., Concord Ventures, Inc., Cavion Technologies Inc

Key figures

Fiscal year to Dec 2025 Dec 2024
Revenue $1.36M$820.1K
Operating income −$3.35M−$3.63M
Net income −$11.1M−$9.91M
Diluted EPS −$0.02−$0.02
Cash from operations −$789.1K−$1.70M
Total assets $7.02M$10.8M
Shareholders’ equity −$30.2M−$19.8M

From the company’s annual reports to the SEC. Each year links to its report.

Financials 112

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Sep 30, 2026
  3. 10-Q Quarterly Report for period ending Jun 30, 2026
  4. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Jun 30, 2026
  5. 10-Q Quarterly Report for period ending Mar 31, 2026
  6. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Mar 31, 2026
  7. 10-K Annual Report for period ending Dec 31, 2025
  8. 10-Q Quarterly Report for period ending Sep 30, 2025
  9. 10-Q Quarterly Report for period ending Jun 30, 2025
  10. 10-Q Quarterly Report for period ending Mar 31, 2025

All 112 financials filings

News 81

  1. 8-K Director or officer change; Other events
  2. 8-K Other events
  3. 8-K Other events
  4. 8-K Other events
  5. 8-K Director or officer change
  6. 8-K Auditor change
  7. 8-K Auditor change
  8. 8-K Director or officer change
  9. 8-K/A Financial statements and exhibits
  10. 8-K Material agreement

All 81 news filings

Ownership 72

  1. 144 Notice of proposed sale of restricted stock
  2. 144 Notice of proposed sale of restricted stock
  3. 3 Initial statement of insider ownership
  4. 3 Initial statement of insider ownership
  5. 3 Initial statement of insider ownership
  6. 4 Change in insider ownership
  7. 4 Change in insider ownership
  8. 3/A Initial statement of insider ownership
  9. 4 Change in insider ownership
  10. 3/A Initial statement of insider ownership

All 72 ownership filings

Prospectus 19

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. S-1/A General form of registration statement for all companies including face-amount certificate companies
  3. RW Registration Withdrawal Request
  4. S-1/A General form of registration statement for all companies including face-amount certificate companies
  5. S-1 General form of registration statement for all companies including face-amount certificate companies
  6. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  7. S-1/A General form of registration statement for all companies including face-amount certificate companies
  8. S-1 General form of registration statement for all companies including face-amount certificate companies
  9. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  10. S-1/A General form of registration statement for all companies including face-amount certificate companies

All 19 prospectus filings

Proxies 15

  1. DEF 14A Definitive proxy statements
  2. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  3. DEF 14A Definitive proxy statements
  4. DEF 14A Definitive proxy statements
  5. DEF 14C Definitive information statements
  6. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  7. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  8. DEF 14A Definitive proxy statements
  9. DEF 14A Definitive proxy statements
  10. DEF 14A Definitive proxy statements

All 15 proxies filings

Other 68

  1. EFFECT Notice of Effectiveness
  2. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  3. UPLOAD Letter (PDF)
  4. EFFECT Notice of Effectiveness
  5. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  6. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  7. UPLOAD Letter (PDF)
  8. EFFECT Notice of Effectiveness
  9. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 68 other filings

Others in Pharmaceutical Preparations

Every company in this industry